Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy.
Heestermans T, van 't Hof AW, ten Berg JM, van Werkum JW, Boersma E, Mosterd A, Stella PR, van Zoelen AB, Gosselink AT, Kochman W, Dill T, Koopmans PC, van Houwelingen G, Zijlstra F, Hamm C. Heestermans T, et al. Among authors: stella pr. Am Heart J. 2010 Dec;160(6):1079-84. doi: 10.1016/j.ahj.2010.08.039. Am Heart J. 2010. PMID: 21146661 Clinical Trial.
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial.
Van't Hof AW, Ten Berg J, Heestermans T, Dill T, Funck RC, van Werkum W, Dambrink JH, Suryapranata H, van Houwelingen G, Ottervanger JP, Stella P, Giannitsis E, Hamm C; Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group. Van't Hof AW, et al. Lancet. 2008 Aug 16;372(9638):537-46. doi: 10.1016/S0140-6736(08)61235-0. Lancet. 2008. PMID: 18707985 Clinical Trial.
Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome.
ten Berg JM, van 't Hof AW, Dill T, Heestermans T, van Werkum JW, Mosterd A, van Houwelingen G, Koopmans PC, Stella PR, Boersma E, Hamm C; On-TIME 2 Study Group. ten Berg JM, et al. Among authors: stella pr. J Am Coll Cardiol. 2010 Jun 1;55(22):2446-55. doi: 10.1016/j.jacc.2009.11.091. J Am Coll Cardiol. 2010. PMID: 20510211 Free article. Clinical Trial.
High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial.
Hermanides RS, Heestermans AA, Ten Berg JM, Gosselink AT, Ottervanger JP, van Houwelingen KG, Kolkman JJ, Stella PR, Dill T, Hamm C, van 't Hof AW. Hermanides RS, et al. Among authors: stella pr. Heart. 2011 Jan;97(2):106-11. doi: 10.1136/hrt.2010.194951. Epub 2010 Oct 20. Heart. 2011. PMID: 20962338 Clinical Trial.
The impact of age on effects of pre-hospital initiation of high bolus dose of tirofiban before primary angioplasty for ST-elevation myocardial infarction.
Hermanides RS, van Houwelingen G, Ottervanger JP, de Boer MJ, Dill T, Hamm C, Stella PR, Boersma E, ten Berg JM, van 't Hof AW; On-TIME 2 trial investigators. Hermanides RS, et al. Among authors: stella pr. Cardiovasc Drugs Ther. 2011 Aug;25(4):323-30. doi: 10.1007/s10557-011-6314-8. Cardiovasc Drugs Ther. 2011. PMID: 21744314 Clinical Trial.
Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score.
Hermanides RS, Ottervanger JP, ten Berg JM, Gosselink AT, van Houwelingen G, Dambrink JH, Stella PR, Hamm C, van 't Hof AW; On-TIME 2 Trial Investigators. Hermanides RS, et al. Among authors: stella pr. J Invasive Cardiol. 2012 Mar;24(3):84-9. J Invasive Cardiol. 2012. PMID: 22388296 Free article. Clinical Trial.
Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death.
Houthuizen P, Van Garsse LA, Poels TT, de Jaegere P, van der Boon RM, Swinkels BM, Ten Berg JM, van der Kley F, Schalij MJ, Baan J Jr, Cocchieri R, Brueren GR, van Straten AH, den Heijer P, Bentala M, van Ommen V, Kluin J, Stella PR, Prins MH, Maessen JG, Prinzen FW. Houthuizen P, et al. Among authors: stella pr. Circulation. 2012 Aug 7;126(6):720-8. doi: 10.1161/CIRCULATIONAHA.112.101055. Epub 2012 Jul 12. Circulation. 2012. PMID: 22791865
Antithrombotic therapy in patients undergoing TAVI: an overview of Dutch hospitals.
Nijenhuis VJ, Stella PR, Baan J, Brueren BR, de Jaegere PP, den Heijer P, Hofma SH, Kievit P, Slagboom T, van den Heuvel AF, van der Kley F, van Garsse L, van Houwelingen KG, Van't Hof AW, Ten Berg JM. Nijenhuis VJ, et al. Among authors: stella pr. Neth Heart J. 2014 Feb;22(2):64-9. doi: 10.1007/s12471-013-0496-6. Neth Heart J. 2014. PMID: 24287807 Free PMC article.
Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.
Nijenhuis VJ, Bennaghmouch N, Hassell M, Baan J Jr, van Kuijk JP, Agostoni P, van 't Hof A, Kievit PC, Veenstra L, van der Harst P, van den Heuvel AF, den Heijer P, Kelder JC, Deneer VH, van der Kley F, Onorati F, Collet JP, Maisano F, Latib A, Huber K, Stella PR, Ten Berg JM. Nijenhuis VJ, et al. Among authors: stella pr. Am Heart J. 2016 Mar;173:77-85. doi: 10.1016/j.ahj.2015.11.008. Epub 2015 Dec 1. Am Heart J. 2016. PMID: 26920599 Clinical Trial.
235 results